Clindamycin Recruiting Phase 3 Trials for Acne Vulgaris Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03522441Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris